Ultragenyx Pharmaceutical RARE Operating margin

Operating margin at other companies

AmgenAMGN

30%+6.5pp

Ionis PharmaceuticalsIONS

-68%-234pp

Arrowhead ResearchARWR

-35.7%+63.6pp

Zevra Therapeutics, Inc.ZVRA

-103.9%-43.0pp

RegenxbioRGNX

-94.1%-9.3pp

CRISPR TherapeuticsCRSP

-15,754.2%-17,253pp

FAQ

What is Ultragenyx Pharmaceutical's operating margin?

Ultragenyx Pharmaceutical (RARE) reported operating margin of -73.6% in Q2 2026.

How has Ultragenyx Pharmaceutical's operating margin changed year-over-year?

Ultragenyx Pharmaceutical's operating margin increased by 11.1% year-over-year, from -82.8% to -73.6%.

What is the long-term trend for Ultragenyx Pharmaceutical's operating margin?

Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's operating margin has grown at a -8.2% compound annual growth rate (CAGR), from -121.8% to -79.5%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.